1Design of the Primary Prevention Parameters Evaluation (PREPARE) trial of implantablecardioverter defibrillators to reduce patient morbidity [NCT00279279]

BACKGROUND: Implantable Cardioverter Defibrillator (ICD) therapy has been proven to be beneficial and efficacious for the treatment of serious ventricular tachyarrhythmias in primary prevention patients. However, primary prevention patients appear to have a lower incidence of ventricular arrhythmias...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilkoff, Bruce L, Stern, Richard, Williamson, Brian, Wathen, Mark, Holloman, Keith, Fieberg, Ann, Brown, Mark
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524810/
https://www.ncbi.nlm.nih.gov/pubmed/16725036
http://dx.doi.org/10.1186/1745-6215-7-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1524810/
https://www.ncbi.nlm.nih.gov/pubmed/16725036
http://dx.doi.org/10.1186/1745-6215-7-18

Ejemplares similares